Kasuwar cephalosporin ta fadi ta hanyar Chengdu Beite biliyan 57 sabon echelon biliyan 1!

1.Kasuwar cephalosporin ta fadi ta hanyar Chengdu Beite biliyan 57 sabon echelon biliyan 1!

Ana amfani da Cephalosporins akai-akai a cikin magungunan asibiti da kuma Top1 sub category na tsarin rigakafi na ƙwayoyin cuta.A cikin 'yan shekarun nan, cephalosporins suma sun zama "abokin ciniki akai-akai" na sayayya na ƙasa.A karkashin tasirin manufofin da yawa, sikelin tallace-tallace na cephalosporins a cikin tashoshin cibiyoyin kiwon lafiya na jama'a a kasar Sin ya sake faduwa a shekarar 2021, ya fadi kasa da yuan biliyan 57.Tallace-tallacen alluran sun farfado kuma adadinsu ya karu.Tsarin masana'antu da yawa na nau'ikan gida waɗanda suka shiga tarin ƙasa ya canza sosai.Kasuwancin magunguna na gabaɗaya yana haɓaka "wurin sarari";A cikin 'yan shekarun nan, da R & D shugabanci na cikin gida Pharmaceutical Enterprises ya mayar da hankali a kan sabon sashi siffofin fili shirye-shirye da foda ruwa biyu jamhuriyar bags, da kuma da dama m sabon kayayyakin suna shirye su je.

2.Oseltamivir ya daina shahara, kuma tsarin magungunan rigakafin mura ya koma baya!

Rahoton mako-mako na cutar mura (6.6-6.12) na Cibiyar mura ta kasa a ranar 17 ga Yuni ya nuna cewa adadin mura kamar lokuta (ili%) a cikin lokuta marasa lafiya da aka ruwaito ta hanyar asibitocin turawa a lardunan kudanci ya kasance 5.8%, sama da matakin cutar. makon da ya gabata (5.1%), sama da matakin daidai wannan lokacin a cikin 2019-2021 (4.4%, 3.0% da 4.3%), ya fi girma fiye da matakin mura kamar lokuta (ili%) a cikin marasa lafiya a cikin lokaci guda. a lokacin barkewar cutar mura a shekarar 2019. Bisa kididdigar da hukumar kula da lafiya ta duniya WHO ta fitar ta ce, tun daga shekarar 2022, bullar cutar mura a yankin arewaci da kudancin kasar ta sake farfadowa sosai.Tun daga watan Yuni, Fujian, Guangdong, Hainan, Jiangxi da sauran wurare sun yi ta yin gargadin gaggawa a jere.Yawan ziyarar marasa lafiya da zazzabi a wasu cibiyoyin kiwon lafiya ya karu, kuma wurare da yawa a Kudancin sun shiga kololuwar mura a lokacin rani.

3.Ƙarfafawa da haɓaka R & D da ƙirƙira da haɓaka damar samun magungunan yara a China.

An kaddamar da aikin zaɓi na kwamitin ba da shawara na ƙwararrun ƙwararrun likitoci don ƙididdige fasaha na magungunan yara, da kuma ƙa'idodin fasaha don ƙira da kimanta dandano na magungunan yara, aikace-aikacen sadarwa da hanyoyin gudanarwa don maganin yara an nemi jama'a don sharhi. … Kwanan nan, jerin sigina masu kyau waɗanda ke ƙarfafa bincike, haɓakawa da samar da magungunan yara sun ja hankalin masana'antu.

4.Dala biliyan 36.7 na magungunan tauraro ne ke kan gaba a jerin, kuma omeprazole da sauran cututtuka na yau da kullun sun ƙare!
Tare da wucewar lokaci, tsarin kasuwancin magunguna na duniya ya sami canje-canje mai girgiza duniya.Omeprazole, simvastatin, atorvastatin da sauran magunguna masu nauyi na cututtukan da ba a taɓa gani ba, waɗanda suka mamaye duniya shekaru 21 da suka gabata kuma aka jera su a matsayin magungunan da aka fi siyar da su, sun bace, kuma an maye gurbinsu da adalimumab, pabolizumab da sauran magungunan rigakafin ƙari da rigakafi.A zamanin da ake samun yawaitar saye da sayarwa da kuma hauhawar kasuwannin harhada magunguna, kamfanonin harhada magunguna na cikin gida sun fara nemo wata hanyar fita, da kirkire-kirkire da sauya sheka, da cunkushe cikin hanyoyin samar da sabbin magunguna daya bayan daya.Fahimtar alkiblar ci gaban kasuwannin harhada magunguna zai zama babban sirrin ga kamfanoni su fice.

5.Inhalant fashe!Manyan kayayyaki 10 a cikin kasuwar biliyan 25 sun tashi sosai.

Kwanan nan, an haɗa inhaler na terbutaline a hukumance a cikin rukuni na bakwai na sayayya na tsakiya, kuma ana sa ran canji na cikin gida zai yi sauri.Bisa kididdigar da aka yi ta intanet, an ce, sayar da magungunan kashe-kashe a cibiyoyin kiwon lafiya na jama'a a kasar Sin ya zarce Yuan biliyan 25 a shekarar 2021, inda ya karu da kashi 26.75 cikin dari a duk shekara.Tallace-tallacen samfuran TOP10 sun sami ci gaba mai kyau, kuma dakatarwar budesonide don shaƙa ta kasance ta farko a jere.Daga cikin samfuran TOP10, an jera samfuran gida guda huɗu kamar Hengrui da Zhengda Tianqing.An kimanta inhalants 10, kuma privet da jiankangyuan ne suka jagoranci jerin, kuma sama da inhalants 10 suna kan bincike bi da bi.

6.Hukumar lafiya ta kasa: matsakaicin tsawon rayuwa a kasar Sin ya karu zuwa shekaru 77.93.

A ran 5 ga wata, hukumar kula da lafiya ta kasar ta gudanar da taron manema labarai kan ci gaba da ingancin ayyukan da Sin ta dauka cikin koshin lafiya tun bayan aiwatar da shi.Mao Qunan, mataimakin darektan ofishin komitin inganta ayyukan kiwon lafiya na kasar Sin, kana daraktan sashen tsare-tsare na hukumar kiwon lafiya ta kasar, ya bayyana a gun taron cewa, a halin yanzu, tsawon rayuwar kowane mutum na kasar Sin ya kai shekaru 77.93, wanda shi ne babban kiwon lafiya. Manufofin sun kasance a sahun gaba a tsakanin kasashe masu tasowa da masu samun kudin shiga, kuma an cimma burin 2020 na shirin "lafiya na kasar Sin na shekarar 2030" a kan jadawalin, an cimma manyan manufofin da Sin ta dauka a shekarar 2022 cikin koshin lafiya. An fara aikin gina kasar Sin mai koshin lafiya da kuma samun ci gaba cikin kwanciyar hankali, inda ta taka muhimmiyar rawa wajen gina al'umma mai matsakaicin wadata daga dukkan fannoni, da sa kaimi ga bunkasuwar tattalin arziki da zamantakewar shirin na shekaru 14 na shekaru biyar.

7.Hukumar lafiya ta kasa: matsakaicin tsawon rayuwar mazauna kasar Sin ya karu zuwa shekaru 78.2.

Hukumar lafiya ta kasar a yau ta fitar da wata sanarwar kididdiga kan ci gaban harkokin kiwon lafiya a shekarar 2021. Sanarwar ta nuna cewa, yawan rayuwar mazauna kasar Sin ya karu daga shekaru 77.93 a shekarar 2020 zuwa shekaru 78.2 a shekarar 2021, adadin mace-macen mata masu juna biyu ya ragu daga 16.9. /100000 zuwa 16.1/100000, kuma yawan mace-macen jarirai ya ragu daga 5.4 ‰ zuwa 5.0 ‰.

JinDun Medicalyana da haɗin gwiwar bincike na kimiyya na dogon lokaci tare da fasahar kere-kere tare da jami'o'in kasar Sin.Tare da wadataccen albarkatun kiwon lafiya na Jiangsu, tana da dangantakar kasuwanci ta dogon lokaci tare da Indiya, kudu maso gabashin Asiya, Koriya ta Kudu, Japan da sauran kasuwanni.Hakanan yana ba da sabis na kasuwa da tallace-tallace a cikin gabaɗayan tsari daga matsakaici zuwa ƙãre samfurin API.Yi amfani da tarin albarkatun Jindun Chemical a cikin sinadarai na fluorine don samarwasabis na gyare-gyaren sinadarai na musammanga abokan tarayya.Samar da sabbin abubuwa da ayyukan bincike na ƙazanta don ƙaddamar da abokan ciniki.